Defunding DEADLY mRNA jabs: Government funding for mRNA technology being scrutinized and sidelined until proven “safe and effective” for real
Recent discussions highlight the growing scrutiny of government funding for mRNA technology, particularly in relation to vaccines. This could significantly affect future research and public health policies.
• Funding Issues: There are concerns about the National Institutes of Health (NIH) regarding its funding for mRNA technology, with reports suggesting scientists are being advised to remove references to mRNA in grant applications due to increased scrutiny, despite a significant research budget of $47 billion.
• Impact on Research: Prominent scientists, including Nobel laureate Drew Weissman, warn that cutting support for NIH could harm scientific progress and push young researchers to leave the country, disrupting years of medical advancements.
• Political Context: Under the potential leadership of RFK Jr. at Health and Human Services, there are calls to withdraw mRNA vaccines from the market until they are proven safe, suggesting possible lives could be saved.
• Claims of Misinformation: The article claims that the public was misled about the mRNA technology used in COVID vaccines. It suggests spike proteins produced by the vaccines continue indefinitely and travel through the body, potentially causing serious health issues, including cancers and other diseases.
• Concerns over NIH: There are allegations that the NIH is corrupt and not transparent about how it spends its budget, with whistleblowers claiming the agency is secretly altering applications to exclude mRNA references.
• Vaccine Safety: The piece calls for a recall of all vaccines and independent safety testing, arguing that current practices have caused significant health problems, including neurological disorders and cancers.
The debate over mRNA vaccine funding and its implications raises critical questions about public health, research integrity, and the future of vaccine safety. Advocates for reform emphasize the need for more transparency and accountability in vaccine development and funding processes.
Comments
Post a Comment